Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease

Kohli-Lynch, C. N., Lewsey, J., Boyd, K. A., French, D. D., Jordan, N., Moran, A. E., Sattar, N., Preiss, D., & Briggs, A. H. (2022). Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation, 145(17), 1312–1323. https://doi.org/10.1161/circulationaha.121.057631
Authors:
Ciaran N. Kohli-Lynch
James Lewsey
Kathleen A. Boyd
Dustin D. French
Neil Jordan
Andrew E. Moran
Naveed Sattar
David Preiss
Andrew H. Briggs
Affiliated Authors:
Andrew E. Moran
Columbia Affiliation:
Subjects:
Cardiovascular Diseases (MeSH)
Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
Health Economics and Quality of Life Assessment (OpenAlex Topic)
Cholesterol-lowering Treatment (OpenAlex Topic)
Economics of Pharmaceutical Research and Development (OpenAlex Topic)
Author Keywords:
cardiovascular diseases
cholesterol
hydroxymethylglutaryl-coa reductase
risk
elink
Publication Type:
Article
Unique ID:
10.1161/CIRCULATIONAHA.121.057631
PMID:
35249370
DOI:
10.1161/CIRCULATIONAHA.121.057631
Journal:
Circulation
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View OpenAlex Record
View PubMed Record

Record Created: